Related references
Note: Only part of the references are listed.Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial
Wolfgang Köhler et al.
LANCET NEUROLOGY (2023)
PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes
Paolo Santambrogio et al.
PHARMACEUTICS (2023)
Prognostic value of global deep white matter DTI metrics for 1-year outcome prediction in ICU traumatic brain injury patients: an MRI-COMA and CENTER-TBI combined study
Louis Puybasset et al.
INTENSIVE CARE MEDICINE (2022)
Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
Robert Chiesa et al.
BLOOD ADVANCES (2022)
Hematopoietic Stem Cell Transplantation for Neurological Disorders: A Focus on Inborn Errors of Metabolism
Pedro de Vasconcelos et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2022)
Massive iron accumulation in PKAN-derived neurons and astrocytes: light on the human pathological phenotype
Paolo Santambrogio et al.
CELL DEATH & DISEASE (2022)
Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy
Hongge Wang et al.
CELLS (2022)
Neuroinflammation in Friedreich's Ataxia
Savina Apolloni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Diagnostic and therapeutic strategies for non-alcoholic fatty liver disease
Yajie Fu et al.
FRONTIERS IN PHARMACOLOGY (2022)
Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia
Massimo Pandolfo et al.
NEUROLOGY-GENETICS (2022)
PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia
Laura Rodriguez-Pascau et al.
NEUROBIOLOGY OF DISEASE (2021)
Multiparametric in vivo analyses of the brain and spine identify structural and metabolic biomarkers in men with adrenomyeloneuropathy
Isaac M. Adanyeguh et al.
NEUROIMAGE-CLINICAL (2021)
Novel in vitro Experimental Approaches to Study Myelination and Remyelination in the Central Nervous System
Davide Marangon et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy
Isabelle Weinhofer et al.
NATURE COMMUNICATIONS (2021)
Concurrent axon and myelin destruction differentiates X-linked adrenoleukodystrophy from multiple sclerosis
Caroline G. Bergner et al.
GLIA (2021)
The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy
Laura Rodriguez-Pascau et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Deuterium-Stabilized (R)-Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity
Vincent Jacques et al.
HEPATOLOGY COMMUNICATIONS (2021)
Selegiline: a molecule with innovative potential
Tamas Tabi et al.
JOURNAL OF NEURAL TRANSMISSION (2020)
Clinical efficacy of haematopoietic stem cell transplantation for adult adrenoleukodystrophy
Takashi Matsukawa et al.
BRAIN COMMUNICATIONS (2020)
PPAR activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
Shidong Lv et al.
BMC CANCER (2019)
Scope of new formulation approaches in the repurposing of pioglitazone for the management of Alzheimer's disease
Gifty M. Jojo et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2019)
Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARγ Drug Pioglitazone
Sarah A. Mosure et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation
Zhi-Bin Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
PPARγ and Cognitive Performance
Michele d'Angelo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation
Gerald V. Raymond et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Longitudinal evaluation of iron concentration and atrophy in the dentate nuclei in friedreich ataxia
Phillip G. D. Ward et al.
MOVEMENT DISORDERS (2019)
Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition
Sonia Levi et al.
PHARMACEUTICALS (2019)
Sensitivity of Volumetric Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy to Progression of Spinocerebellar Ataxia Type 1
Dinesh K. Deelchand et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2019)
Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation
Anthony Drecourt et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Impaired plasticity of macrophages in X-linked adrenoleukodystrophy
Isabelle Weinhofer et al.
BRAIN (2018)
Classification and molecular pathogenesis of NBIA syndromes
Ivano Di Meo et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)
Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
Shreekrishna Lamichane et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma
Patricia Corrales et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy
Kurt A. Jellinger
JOURNAL OF ALZHEIMERS DISEASE (2018)
Interactions of iron-bound frataxin with ISCU and ferredoxin on the cysteine desulfurase complex leading to Fe-S cluster assembly
Kai Cai et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
Use of brain diffusion tensor imaging for the prediction of long-term neurological outcomes in patients after cardiac arrest: a multicentre, international, prospective, observational, cohort study
Lionel Velly et al.
LANCET NEUROLOGY (2018)
Mitochondrial dysfunction in the neuro-degenerative and cardio-degenerative disease, Friedreich's ataxia
Shannon Chiang et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Wei Cai et al.
PROGRESS IN NEUROBIOLOGY (2018)
Adiponectin Regulates the Polarization and Function of Microglia via PPAR-γ Signaling Under Amyloid β Toxicity
Juhyun Song et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-ß/δ and PPAR-γ
Lu Han et al.
FUTURE CARDIOLOGY (2017)
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
Juan M. Zolezzi et al.
BIOLOGICAL REVIEWS (2017)
Long-term outcomes of allogeneic haematopoietic stem cell transplantation for adult cerebral X-linked adrenoleukodystrophy
Joern-Sven Kuehl et al.
BRAIN (2017)
Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders
Swati Agarwal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Neuroinflammation impairs adaptive structural plasticity of dendritic spines in a preclinical model of Alzheimer's disease
Chengyu Zou et al.
ACTA NEUROPATHOLOGICA (2016)
PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
Juan Carlos Corona et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Tissue atrophy and elevated iron concentration in the extrapyramidal motor system in Friedreich ataxia: the IMAGE-FRDA study
Ian H. Harding et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
The effect of diet interventions on hypothalamic nutrient sensing pathways in rodents
Merel Rijnsburger et al.
PHYSIOLOGY & BEHAVIOR (2016)
Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis
Laura Negrotto et al.
JAMA NEUROLOGY (2016)
Localization of PPAR isotypes in the adult mouse and human brain
Anna Warden et al.
SCIENTIFIC REPORTS (2016)
Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway
Gang Wang et al.
SCIENTIFIC REPORTS (2016)
Brain endothelial dysfunction in cerebral adrenoleukodystrophy
Patricia L. Musolino et al.
BRAIN (2015)
The Role of Mitochondrially Derived ATP in Synaptic Vesicle Recycling
Divya Pathak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression
Thiruchelvam Kariharan et al.
NEUROBIOLOGY OF AGING (2015)
Mitochondrial iron and energetic dysfunction distinguish fibroblasts and induced neurons from pantothenate kinase-associated neurodegeneration patients
Paolo Santambrogio et al.
NEUROBIOLOGY OF DISEASE (2015)
Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2
Borna Payandemehr et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2015)
A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism
Ali Ghaleiha et al.
PSYCHIATRY RESEARCH (2015)
Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson's disease
Anna R. Carta et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Activity-Driven Local ATP Synthesis Is Required for Synaptic Function
Vidhya Rangaraju et al.
CELL (2014)
Progressive multiple sclerosis cerebrospinal fluid induces inflammatory demyelination, axonal loss, and astrogliosis in mice
Massimiliano Cristofanilli et al.
EXPERIMENTAL NEUROLOGY (2014)
Mitochondrial Dysfunction in Central Nervous System White Matter Disorders
Laia Morato et al.
GLIA (2014)
Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer
Woonyoung Choi et al.
NATURE REVIEWS UROLOGY (2014)
Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy
Marlijn de Beer et al.
NEUROLOGY (2014)
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
Bogna Grygiel-Gorniak
NUTRITION JOURNAL (2014)
Role of PPARγ in the Differentiation and Function of Neurons
Rodrigo A. Quintanilla et al.
PPAR RESEARCH (2014)
Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy
Laia Morato et al.
BRAIN (2013)
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
Hanford Yau et al.
CURRENT DIABETES REPORTS (2013)
Iron-sulfur cluster synthesis, iron homeostasis and oxidative stress in Friedreich ataxia
Rachael A. Vaubel et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson's Disease?
Anna R. Carta et al.
NEUROTOXICITY RESEARCH (2013)
Cortical energy demands of signaling and nonsignaling components in brain are conserved across mammalian species and activity levels
Fahmeed Hyder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia
Shannon L. Risacher et al.
SEMINARS IN NEUROLOGY (2013)
Higher Expression of Peroxisome Proliferator-activated Receptor γ or Its Activation by Agonist Thiazolidinedione-rosiglitazone Promotes Bladder Cancer Cell Migration and Invasion
Dong-Rong Yang et al.
UROLOGY (2013)
X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects
Stephan Kemp et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA Parkinsonian model is associated with inhibition of microglial activation and MMP expression
M. Sadeghian et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) and Neurodegenerative Disorders
Yu-Chang Chen et al.
MOLECULAR NEUROBIOLOGY (2012)
Rosiglitazone enhances learning, place cell activity, and synaptic plasticity in middle-aged rats
Boon Wan Wang et al.
NEUROBIOLOGY OF AGING (2012)
PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease
Ming-Chang Chiang et al.
NEUROBIOLOGY OF DISEASE (2012)
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway
Gohar Fakhfouri et al.
NEUROPHARMACOLOGY (2012)
X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
Marc Engelen et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity
Troy C. Lund et al.
PLOS ONE (2012)
Metabolic State Determines Sensitivity to Cellular Stress in Huntington Disease: Normalization by Activation of PPARγ
Youngnam N. Jin et al.
PLOS ONE (2012)
A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
Luc Dupuis et al.
PLOS ONE (2012)
Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction
Kathryn A. Thibert et al.
PLOS ONE (2012)
Amyloid Beta Induces Oxidative Stress-Mediated Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy
Anna Carrano et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Protective effect of pioglitazone, a PPARγ ligand, in a 3 nitropropionic acid model of Huntington's disease
Maddalena Napolitano et al.
BRAIN RESEARCH BULLETIN (2011)
Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimer's Disease: Two Phase 3 Studies
C. Harrington et al.
CURRENT ALZHEIMER RESEARCH (2011)
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
Christine R. Swanson et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Pioglitazone Reduces Secondary Brain Damage after Experimental Brain Trauma by PPAR-γ-Independent Mechanisms
Serge C. Thal et al.
JOURNAL OF NEUROTRAUMA (2011)
A role for central nervous system PPAR-γ in the regulation of energy balance
Karen K. Ryan et al.
NATURE MEDICINE (2011)
NEUROPROTECTIVE EFFECTS OF PIOGLITAZONE IN A RAT MODEL OF PERMANENT FOCAL CEREBRAL ISCHEMIA ARE ASSOCIATED WITH PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA-MEDIATED SUPPRESSION OF NUCLEAR FACTOR-κB SIGNALING PATHWAY
H-L. Zhang et al.
NEUROSCIENCE (2011)
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis
Ranjan Dutta et al.
PROGRESS IN NEUROBIOLOGY (2011)
The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases
Sandeep Tyagi et al.
JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH (2011)
PPARs: diverse regulators in energy metabolism and metabolic diseases
Yong-Xu Wang
CELL RESEARCH (2010)
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer's Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
Michael Gold et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
A Prospective Analysis of Elevated Fasting Glucose Levels and Cognitive Function in Older People Results From PROSPER and the Rotterdam Study
Sjoerd M. Euser et al.
DIABETES (2010)
The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy
Rob Ofman et al.
EMBO MOLECULAR MEDICINE (2010)
Regulation of mitochondrial biogenesis
Francois R. Jornayvaz et al.
ESSAYS IN BIOCHEMISTRY: MITOCHONDRIAL FUNCTION (2010)
Thiazolidinediones and Fractures: Evidence from Translating Research into Action for Diabetes
Dori Bilik et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
PGC-1alpha Down-Regulation Affects the Antioxidant Response in Friedreich's Ataxia
Daniele Marmolino et al.
PLOS ONE (2010)
Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: Possible role of peroxisome proliferator activated receptor-Γ (PPARΓ) in Huntington's disease
Harikesh Kalonia et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Iron-sulfur proteins in health and disease
Alex Sheftel et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Thiazolidinediones and Fractures in Men and Women
Colin R. Dormuth et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
Yoon K. Loke et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes An Overview of Data from PROactive
John Dormandy et al.
DRUG SAFETY (2009)
Direct measurement of oxidative metabolism in the living brain by microdialysis: a review
H. Ronald Zielke et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Friedreich ataxia: The clinical picture
Massimo Pandolfo
JOURNAL OF NEUROLOGY (2009)
Peroxisome Proliferator-Activated Receptor-γ Agonists Promote Differentiation and Antioxidant Defenses of Oligodendrocyte Progenitor Cells
Antonietta Bernardo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Neuronal PPARγ Deficiency Increases Susceptibility to Brain Damage after Cerebral Ischemia
Xiurong Zhao et al.
JOURNAL OF NEUROSCIENCE (2009)
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
David N. Juurlink et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Use of thiazolidinediones and fracture risk
Christian Meier et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters
Carlo W. T. van Roermund et al.
FASEB JOURNAL (2008)
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Ramya Kapadia et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
CPT1c is localized in endoplasmic reticulum of neurons and has carnitine palmitoyltransferase activity
Adriana Y. Sierra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Rosiglitazone treatment prevents mitochondrial dysfunction in mutant huntingtin-expressing cells -: Possible role of peroxisome proliferator-activated receptor-γ (PPARγ) in the pathogenesis of Huntington disease
Rodrigo A. Quintanilla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Remyelination in the CNS: from biology to therapy
Robin J. M. Franklin et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons
Jens Brodbeck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The Development of INT131 as a Selective PPAR. Modulator: Approach to a Safer Insulin Sensitizer
Linda S. Higgins et al.
PPAR RESEARCH (2008)
X-linked adrenoleukodystrophy
P. Aubourg
ANNALES D ENDOCRINOLOGIE (2007)
The transcriptome and metabolic gene signature of protoplasmic Astrocytes in the adult murine cortex
Ditte Lovatt et al.
JOURNAL OF NEUROSCIENCE (2007)
Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats
Borja Garcia-Bueno et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy
Florian Eichler et al.
ARCHIVES OF NEUROLOGY (2007)
Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum
C. M. Kusminski et al.
DIABETOLOGIA (2007)
Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production
Tae Woo Jung et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Effect of pioglitazone treatment on behavioral symptoms in autistic children
Marvin Boris et al.
JOURNAL OF NEUROINFLAMMATION (2007)
Immunopathogenesis of adrenoleukodystrophy: Current understanding
Michelle P. Hudspeth et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Pioglitazone as a therapeutic agent in autistic spectrum disorder
Enzo Emanuele et al.
MEDICAL HYPOTHESES (2007)
Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis
David Liebetanz et al.
EXPERIMENTAL NEUROLOGY (2006)
PPAR-gamma agonists as regulators of microglial activation and brain inflammation
A Bernardo et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Risk of dementia in diabetes mellitus: a systematic review
GJ Biessels et al.
LANCET NEUROLOGY (2006)
The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice
B Schütz et al.
JOURNAL OF NEUROSCIENCE (2005)
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice
MT Heneka et al.
BRAIN (2005)
Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo
I Bogacka et al.
DIABETES (2005)
Role of oxidative damage in Friedreich's ataxia
JL Bradley et al.
NEUROCHEMICAL RESEARCH (2004)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients
Y Miyazaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity
AL Bulteau et al.
SCIENCE (2004)
Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS
S Moreno et al.
NEUROSCIENCE (2004)
Peroxisome proliferator-activated receptor γ thiazolidinedione agonists increase glucose metabolism in astrocytes
C Dello Russo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Thiazolidinedione activation of peroxisome proliferator-activated receptor γ can enhance mitochondrial potential and promote cell survival
YL Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-γ
M Niino et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Survival activity of troglitazone in rat motoneurones
C Nishijima et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Increased levels of plasma malondialdehyde in Friedreich ataxia
M Emond et al.
NEUROLOGY (2000)
Oxidative stress in patients with Friedreich ataxia
JB Schulz et al.
NEUROLOGY (2000)
X-linked adrenoleukodystrophy: Overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients
HW Moser et al.
NEUROPEDIATRICS (2000)
Share Paper
